Revised forecast
Fiscal year ending March 2027 · Full yearThe bar length represents the relative magnitude of change, based on the item that changed the most in this document.
Revised after taking into account results for the current interim consolidated accounting period and factors affecting changes in the business environment.
Loss on termination of the retirement benefit plan: ¥6,408 million. Total extraordinary losses: ¥7,762 million.
| Item | Details |
|---|---|
| Net Sales | ¥8,500 100 million → ¥8,750 100 million(+2.9%) |
| Operating profit | ¥940 100 million → ¥990 100 million(+5.3%) |
| Ordinary income | ¥1,000 100 million → ¥1,040 100 million(+4.0%) |
| Profit attributable to owners of the parent | ¥800 100 million → ¥780 100 million(-2.5%) |
| Net income per share | Not disclosed → 136.34 yen/sen |
| Fiscal Period Covered | Fiscal year ending March 2027 |
| Period Covered | Full year |
| Reason for the revision | Revised after taking into account results for the current interim consolidated accounting period and factors affecting changes in the business environment. |
| Details and amount of extraordinary loss | Loss on termination of the retirement benefit plan: ¥6,408 million. Total extraordinary losses: ¥7,762 million. |
| Dividend forecast revision | Revised. The dividend per share at the end of the second quarter is ¥140.00, and the forecast year-end dividend for the fiscal year ending March 2027 is ¥18.00. The revision reflects the stock split effective 1 October 2026, so the direction of the change cannot be determined. |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (2)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.This reflects consideration of results for the current interim consolidated accounting period and factors affecting changes in the business environment.